• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION SHRT GEN / PRO 18 X 60 BIL 80; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION SHRT GEN / PRO 18 X 60 BIL 80; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number PG1860BPS
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 01/01/1980
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product was not returned for analysis.No lot number was provided therefore a product history record (phr) review could not be generated.The reported ¿aneurysm¿ could not be confirmed as the device was not returned for analysis nor were images provided for review.The exact cause could not be determined.Vessel characteristics are unknown.The location of the implanted stent was not provided.Erroneous contact information was provided therefore it was not possible to contact the patient for additional information.Currently there is no medical evidence to suggest a causal relationship between the reported adverse event and stent implantation.As no lot number or other product information was supplied a phr could not be completed.According to the safety information in the instructions for use ¿the cordis palmaz genesis transhepatic biliary stent on opta pro.035¿ delivery system is indicated for palliation of malignant neoplasms in the biliary tree.The safety and effectiveness of the palmaz genesis transhepatic biliary stent on opta pro.035¿ delivery system for use in the vascular system have not been established.Prior to stenting, the palmaz genesis transhepatic biliary stent on opta pro.035¿ delivery system should be examined to verify functionality and integrity.¿ the very limited information available does not suggest a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken at this time.
 
Event or Problem Description
The patient had a procedure with 80cm palmaz genesis transhepatic biliary stent on.035" 18 x 60 opta pro balloon expandable stent delivery system (sds) approximately 15 years ago and about a year after, got a brain aneurysm.The patient believed that the decomposing stent was the cause of her brain aneurysm.Her chief complaint was that she got the brain aneurysm due to the stent "breaking down" and she had reported this to her physician.She stated that her physician mentioned that there was not enough research on this for the brain aneurysm.The patient wanted to know the material composition of the stent, balloon, and guidewire for palmaz genesis on opta pro and the stent composition of the smart control.The device will not be returned for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHRT GEN / PRO 18 X 60 BIL 80
Common Device Name
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th avenue
miami lakes FL 33014
MDR Report Key11877936
Report Number9616099-2021-04577
Device Sequence Number3559677
Product Code FGE
UDI-Device Identifier20705032038321
UDI-Public20705032038321
Combination Product (Y/N)N
PMA/510(K) Number
K012590
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 05/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberPG1860BPS
Device Catalogue NumberPG1860BPS
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/06/2021
Initial Report FDA Received Date05/25/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-